A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)

por Leav, Brett, Straus, Walter, White, Phil, Leav, Alison, Gaines, Tashawnee, Maggiacomo, Grace, Kim, Denny, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
Publicado 2022

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment

por Folegatti, Pedro M, Jenkin, Daniel, Morris, Susan, Gilbert, Sarah, Kim, Denny, Robertson, James S., Smith, Emily R., Martin, Emalee, Gurwith, Marc, Chen, Robert T.
Publicado 2022

The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform

por Volkmann, Ariane, Williamson, Anna-Lise, Weidenthaler, Heinz, Meyer, Thomas P.H., Robertson, James S., Excler, Jean-Louis, Condit, Richard C., Evans, Eric, Smith, Emily R., Kim, Denny, Chen, Robert T.
Publicado 2021

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines

por Condit, Richard C, Kim, Denny, Robertson, James S., Excler, Jean-Louis, Gurwith, Marc, Monath, Thomas P., Pavlakis, George, Fast, Patricia E., Smith, Jonathan, Smith, Emily R., Chen, Robert T., Kochhar, Sonali
Publicado 2020

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines

por Kim, Denny, Robertson, James S., Excler, Jean-Louis, Condit, Richard C., Fast, Patricia E., Gurwith, Marc, Pavlakis, George, Monath, Thomas P., Smith, Jonathan, Wood, David, Smith, Emily R., Chen, Robert T., Kochhar, Sonali
Publicado 2020

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines

por Kochhar, Sonali, Kim, Denny, Excler, Jean-Louis, Condit, Richard C., Robertson, James S., Drew, Stephen, Whelan, Mike, Wood, David, Fast, Patricia E., Gurwith, Marc, Klug, Bettina, Khuri-Bulos, Najwa, Smith, Emily R., Chen, Robert T
Publicado 2020

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment()

por Custers, Jerome, Kim, Denny, Leyssen, Maarten, Gurwith, Marc, Tomaka, Frank, Robertson, James, Heijnen, Esther, Condit, Richard, Shukarev, Georgi, Heerwegh, Dirk, van Heesbeen, Roy, Schuitemaker, Hanneke, Douoguih, Macaya, Evans, Eric, Smith, Emily R., Chen, Robert T.
Publicado 2021

Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains

por Condit, Richard C., Williamson, Anna-Lise, Sheets, Rebecca, Seligman, Stephen J., Monath, Thomas P., Excler, Jean-Louis, Gurwith, Marc, Bok, Karin, Robertson, James S., Kim, Denny, Michael Hendry, R., Singh, Vidisha, Mac, Lisa M., Chen, Robert T.
Publicado 2016

Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated vir...

por Gurwith, Marc, Condit, Richard C., Excler, Jean-Louis, Robertson, James S., Kim, Denny, Fast, Patricia E., Drew, Stephen, Wood, David, Klug, Bettina, Whelan, Mike, Mallett Moore, Tamala, Khuri-Bulos, Najwa, Smith, Emily R., Chen, Robert T, Kochhar, Sonali
Publicado 2020

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines

por Kochhar, Sonali, Excler, Jean-Louis, Kim, Denny, Robertson, James S., Fast, Patricia E., Condit, Richard C., Drew, Stephen, Wood, David, Gurwith, Marc, Klug, Bettina, Whelan, Mike, Khuri-Bulos, Najwa, Mallett Moore, Tamala, Smith, Emily R., Chen, Robert T.
Publicado 2020